CME Group (TICKER: CME) Benchmark And Performance Data

there are 7 of samples in the benchmark for CME Group in year 2022 in 2022. The total inventory for CME Group was $0.00 in 2021. The total inventory for CME Group was $0.00 in 2020. The total inventory for CME Group was $0.00 in 2019. The total inventory for CME Group was $0.00 in 2018. The total inventory for CME Group was $0.00 in 2017. The total inventory for CME Group was $0.00 in 2016. The total inventory for CME Group was $0.00 in 2015. The total inventory for CME Group was $0.00 in 2014. The total inventory for CME Group was $0.00 in 2013. The total inventory for CME Group was $0.00 in 2012. The sales, general, and administrative (SGA) for CME Group was $225,800,000.00 in 2014. The sales, general, and administrative (SGA) for CME Group was $215,300,000.00 in 2015. The sales, general, and administrative (SGA) for CME Group was $208,600,000.00 in 2013. The sales, general, and administrative (SGA) for CME Group was $203,800,000.00 in 2012. The sales, general, and administrative (SGA) for CME Group was $191,300,000.00 in 2020. The sales, general, and administrative (SGA) for CME Group was $174,100,000.00 in 2019. The sales, general, and administrative (SGA) for CME Group was $166,100,000.00 in 2018. The sales, general, and administrative (SGA) for CME Group was $151,700,000.00 in 2021. The sales, general, and administrative (SGA) for CME Group was $144,400,000.00 in 2016. The sales, general, and administrative (SGA) for CME Group was $117,600,000.00 in 2017. The sales, general, and administrative (SGA) for CME Group was $$137,000,000 in 2022. The revenue volatility for CME Group was 5.17% in 2022. The market capitalization for CME Group was $85,304,716,063.00 in 2015. The market capitalization for CME Group was $81,926,235,766.00 in 2014. The market capitalization for CME Group was $76,204,974,788.00 in 2012. The market capitalization for CME Group was $73,421,824,247.00 in 2016. The market capitalization for CME Group was $72,029,013,052.00 in 2021. The market capitalization for CME Group was $69,341,646,944.00 in 2013. The market capitalization for CME Group was $68,743,066,108.00 in 2019. The market capitalization for CME Group was $66,515,615,058.00 in 2020. The market capitalization for CME Group was $63,568,438,842.00 in 2017. The market capitalization for CME Group was $60,491,880,153.00 in 2018. The market capitalization for CME Group was $$73,536,000,000 in 2022. The gross revenue for CME Group was $4,883,600,000.00 in 2020. The gross revenue for CME Group was $4,868,000,000.00 in 2019. The gross revenue for CME Group was $4,689,700,000.00 in 2021. The gross revenue for CME Group was $4,309,400,000.00 in 2018. The gross revenue for CME Group was $3,644,700,000.00 in 2017. The gross revenue for CME Group was $3,595,200,000.00 in 2016. The gross revenue for CME Group was $3,326,800,000.00 in 2015. The gross revenue for CME Group was $3,112,500,000.00 in 2014. The gross revenue for CME Group was $2,936,300,000.00 in 2013. The gross revenue for CME Group was $2,914,600,000.00 in 2012. The gross revenue for CME Group was $$5,019,000,000 in 2022. The gross margin for CME Group was $60.08% in 2022. The days sales outstanding for CME Group was 33 days in 2022. The days payable outstanding for CME Group was 41 days in 2022. The days of inventory for CME Group was $0 in 2022. The cost of goods sold (COGS) for CME Group was 15.00% in 2022. The cost of goods sold (COGS) for CME Group was $898,700,000.00 in 2019. The cost of goods sold (COGS) for CME Group was $856,500,000.00 in 2020. The cost of goods sold (COGS) for CME Group was $837,000,000.00 in 2021. The cost of goods sold (COGS) for CME Group was $672,200,000.00 in 2018. The cost of goods sold (COGS) for CME Group was $584,100,000.00 in 2014. The cost of goods sold (COGS) for CME Group was $581,500,000.00 in 2015. The cost of goods sold (COGS) for CME Group was $563,900,000.00 in 2017. The cost of goods sold (COGS) for CME Group was $554,200,000.00 in 2013. The cost of goods sold (COGS) for CME Group was $543,200,000.00 in 2016. The cost of goods sold (COGS) for CME Group was $536,800,000.00 in 2012. The cost of goods sold (COGS) for CME Group was $$753,000,000 in 2022. The cash to cash cycle time for CME Group was -8 in 2022. The annual percentage growth rate of CME Group was -0.07% in 2022. CME Group in its benchmark peer group, had rank 5 for sales growth in 2022. CME Group in its benchmark peer group, had rank 5 for gross revenue in 2022. CME Group in its benchmark peer group, had rank 3 for cash to cash cycle time in 2022. CME Group in its benchmark peer group, had rank 3 days for days sales outstanding in 2022. CME Group in its benchmark peer group, had rank 1 for cost of goods sold as a percent of revenue in 2022. CME Group in its benchmark peer group, had rank 1 days for days of inventory in 2022. CME Group headquarters region is Central. CME Group has ticker symbol CME. CME Group has the following profile: CME Group Inc. , together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services.. CME Group has primary indstury Financial Data & Stock Exchanges. CME Group had a $$449,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. CME Group had S&P Global Inc., and Intercontinental Exchange, and Moody's, and Cboe Global Markets, and CME Group, and Nasdaq, and Coinbase Global benchmark peer companies for its SIC code in 2022. CME Group had 3,460 number of employees in 2022. CME Group had 2 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. CME Group had 13 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. CME Group had 0.01% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. CME Group had 0.00% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. CME Group had 0.00% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. CME Group had 0.00% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. CME Group had 0 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. CME Group can reduce overall cost by $$0 by improving both COGS and SGA to next benchmark tier in 2022. CME Group can reduce inventory with practices including in 2022. CME Group can reduce days sales outstanding with practices including Customer Satisfaction (VOC) in 2022. CME Group can increase sales revenue by $$449,000,000 improving sales performance to next benchmark tier in 2022. CME Group can increase revenue growth by $$1,000,000 by improving growth performance to next benchmark tier in 2022. CME Group can increase overall revenue by $$449,000,000 by improving both growth and sales performance to next benchmark tier in 2022. CME Group can increase days payables outstanding with practices including in 2022. CME Group can increase days payables outstanding by $132,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. CME Group can improve total financial performance by $$760,000,000 by improving revenue, costs, and working capital in 2022. CME Group can decrease overall working capital by $$311,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. CME Group can decrease inventory days by $0 days by reducing inventory days to next benchmark tier in 2022. CME Group can decrease days sales outstanding by $179,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. CME Group can accelerate revenue growth practices including Revenue-optimized Planning in 2022. CME Group can accelerate revenue growth practices including Pricing Optimization in 2022. CME Group can accelerate revenue growth practices including Customer Satisfaction / VOC in 2022. CME Group can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 8.95% was the measured superior or top ten performance level for sales volatility in CME Group's peer group in 2022. 47.27% was the measured superior or top ten performance level for gross margin in CME Group's peer group in 2022. 37 days was the measured parity or middle performance level for days sales outstanding in CME Group's peer group in 2022. 33.68% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in CME Group's peer group in 2022. 33 days was the measured advantage or top third performance level for days sales outstanding in CME Group's peer group in 2022. 27.54% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in CME Group's peer group in 2022. 20 days was the measured superior or top ten performance level for days sales outstanding in CME Group's peer group in 2022. 20 days was the measured parity or middle performance level for cash to cash cycle time in CME Group's peer group in 2022. 17.83% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in CME Group's peer group in 2022. 16.33% was the measured parity or middle performance level for sales volatility in CME Group's peer group in 2022. 14.90% was the measured advantage or top third performance level for sales volatility in CME Group's peer group in 2022. 0.31% was the measured superior or top ten performance level for sales growth in CME Group's peer group in 2022. 0 days was the measured superior or top ten performance level for days of inventory in CME Group's peer group in 2022. 0 days was the measured parity or middle performance level for days of inventory in CME Group's peer group in 2022. 0 days was the measured advantage or top third performance level for days of inventory in CME Group's peer group in 2022. -22 days was the measured superior or top ten performance level for cash to cash cycle time in CME Group's peer group in 2022. -10 days was the measured advantage or top third performance level for cash to cash cycle time in CME Group's peer group in 2022. -0.06% was the measured parity or middle performance level for sales growth in CME Group's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in CME Group's peer group in 2022. $36.96% was the measured advantage or top third performance level for gross margin in CME Group's peer group in 2022. $27.00% was the measured parity or middle performance level for gross margin in CME Group's peer group in 2022. $$6,908,000,000 was the measured advantage or top third performance level for gross revenue in CME Group's peer group. $$5,468,000,000 was the measured parity or middle performance level for gross revenue in CME Group's peer group in 2022. $$10,254,000,000 was the measured superior or top ten performance level for gross revenue in CME Group's peer group in 2022.